Phenotypic reversion of rat neoplastic liver nodules is under genetic control

International Journal of Cancer

Volumn 105, Issue 1, 2003, Pages 70-75

  De Miglio, Maria R ^a   Simile, Maria M ^a   Muroni, Maria R ^a   Calvisi, Diego F ^a   Virdis, Patrizia ^a   Asara, Giuseppina ^a   Frau, Maddalena ^a   Bosinco, Giovanni M ^a   Seddaiu, Maria A ^a   Daino, Lucia ^a   Feo, Francesco ^a   Pascale, Rosa M ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Genomic scanning; Hepatocarcinogenesis; Linkage analysis; Neoplastic nodule; Phenotypic reversion; Quantitative trait loci

Indexed keywords

DIETHYLNITROSAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 1; CHROMOSOME 7; CONTROLLED STUDY; DNA SYNTHESIS; GENE INTERACTION; GENE LOCUS; GENE MAPPING; GENETIC EPISTASIS; GENETIC LINKAGE; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER TUMOR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ALLELES; ANIMALS; CHROMOSOME MAPPING; EPISTASIS, GENETIC; GENOTYPE; GLUTATHIONE TRANSFERASE; LINKAGE (GENETICS); LIVER NEOPLASMS; LOD SCORE; NEOPLASMS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED F344;

EID: 0037457642     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11044     Document Type: Article

References (47)

1. Dragani TA, Canzian F, Pierotti MA. A polygenic model of inherited predisposition to cancer. FASEB J 1996;10:865-70.
2. Feo F, Pascale RM. Polygenic control of susceptibility and resistance to hepatocarcinogenesis. In: Dragani TA, ed. Human polygenic diseases. Animal models. Amsterdam: Harwood, 1998, 189-216.
3. Wood GA, Korkola JE, Archer MC. Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes. Carcinogenesis 2002;23:1-9.
4. Feo F, Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit Rev Oncog 2000;11:19-62.
5. Drinkwater NR, Ginsler JJ. Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 1986;7: 1701-7.
6. Gariboldi M, Manenti G, Canzian F, Favella FS, Pienotti MA, Della Porta G, Binelli G, Dragani TA. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res 1993;15:209-11.
7. Manenti G, Binelli G, Gariboldi M, Canzian F, De Gregorio L, Favella FS, Dragani TA, Pienotti MA. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics 1994;23: 118-24.
8. Lee GH, Drinkwater NR. The Hcr (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotype expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ mice. Carcinogenesis 1995;16:1993-6.
9. Poole TM, Drinkwater NR. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc Natl Acad Sci USA 1996;93:5848-53.
10. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Gaspa L, Dragani TA, Feo F. The BN rat strain carries dominant hepatocarcinogen resistance loci. Carcinogenesis 1996;17:1765-8.
11. De Miglio MR, Canzian F, Pascale RM, Simile MM, Muroni MR, Calvisi D, Romeo G, Feo F. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10. Cancer Res 1999;59:4651-7.
12. De Miglio MR, Pascale RM, Simile MM, Muroni MR, Calvisi DF, Virdis P, Bosinco GM, Frau M, Seddaiu MA, Ladu S, Feo F. Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis. Cancer Res 2002;62:4459-63.
13. Zeng Z-Z, Higashi S, Kitayama W, Denda A, Yan Y, Matsuo K, Konishi Y, Hiai H, Higashi K. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats. Cancer Res 2000;60:2876-81.
14. Melhem MF, Kunz HW, Gill TJ III. A major histocompatibility complex-linked locus in the rat critically influences resistance to diethylnitrosamine carcinogenesis. Proc Natl Acad Sci USA 1993;90: 1967-71.
15. Farber E, Sarma DSR. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987;56:4-22.
16. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P. Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 1997;431:391-406.
17. Teebor GW, Becker FF. Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluorenylacetamide and their relationship with hepatocarcinogenesis. Cancer Res 1971;31:1-3.
18. Kitagawa T. Sequential phenotypic changes in hyperplastic areas during hepatocarcinogenesis in the rat. Cancer Res 1976;36:2534-9.
19. Enomoto K, Farber E. Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis. Cancer Res 1982;42:2330-5.
20. Moore MA, Hacker J, Bannasch P. Phenotypic instability in focal and nodular lesions induced by a short term system in rat liver. Carcinogenesis 1983;4:595-603.
21. Tatematsu M, Nagamine Y, Farber E. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normally appearing liver. Cancer Res 1983;43:5049-58.
22. Garcea R, Daino L, Pascale RM, Simile MM, Puddu M, Frassetto S, Cozzolino P, Seddaiu MA, Gaspa L, Feo F. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. Cancer Res 1989;49:1850-6.
23. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990;50:5127-35.
24. De Miglio MR. Simile MM, Muroni MR, Pusceddu S, Calvisi D, Carru A, Seddaiu MA, Daino L, Deiana L, Pascale RM, Feo F. c-myc overexpression and amplification correlate with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain. Mol Carcinogen 1999;25:21-9.
25. Denda A, Kitayama W, Konishi Y, Yan Y, Fykamachi Y, Miura M, Gotoh S, Ikemura K, Abe T, Higashi T, Higashi K. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats Cancer Lett 1999;140:59-67.
26. Wood GA, Korkola JE, Lee VM, Sarma DRS, Archer MC. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7-7-positive liver foci. Carcinogenesis 1997;18:1745-50.
27. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA, Feo F. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 2002;35:1341-50.
28. Solt DB, Medline A, Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model of sequential analysis of liver carcinogenesis Am J Pathol 1977;88:595-618.
29. Pugh TD, King JH, Koen H, Nychka D, Chover J, Wahba G, He Y-H, Goldfarb S. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cancer Res 1983;43:1261-8.
30. Pascale RM, Marras V, Simile MM, Daino L, Pinna G, Bennati S, Carta M, Seddaiu MA, Massarelli G, Feo F. Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. Cancer Res 1992;52:4979-86.
31. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
32. Lander ES, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;1:241-7.
33. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 1981;35:124-9.
34. Canzian F, Ushijima T, Pascale RM, Sugimura T, Dragani TA, Nagao M. Construction of a phylogenetic tree for inbred strains of rat by arbitrarily primed polymerase chain reaction (AP-PCR). Mamm Genome 1995;6:231-5.
35. Barton NH, Keightley PD. Understanding quantitative genetic variation. Nat Rev Genet 2002;3:11-21.
36. Nasi S, Ciarapica R, Jucker R, Rosati J, Souceck L. Making decisions through Myc. FEBS Lett 2001;490:153-62.
37. Pascale RM, Simile MM, Gaspa L, Daino L, Seddaiu MA, Pinna G, Carta M, Zolo P, Feo F. Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. Carcinogenesis 1993;14:1077-80.
38. Sanae F, Kohei K, Nomura M, Miyamoto K. Studies on responsiveness of hepatoma cells to catecholamines. VI. Characteristics of adrenoceptors and adenylate cyclase response in rat ascites hepatoma cells and human hepatoma cells. J Pharmacobiodyn 1992;15:303-9.
39. Kang-Park S, Lee JH, Shin JH, Lee YI. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 MAP kinase signaling. Biochem Biophys Res Commun 2001;283:303-7.
40. Chang B, Zheng SL, Isaacs SD, Wiley KE, Carpten JD, Hawkins GA, Cleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB, Xu J. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer. Int J Cancer 2001;95:354-9.
41. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM, Vhen CJ. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644-51.
42. De Miglio MR, Muroni MR, Simile MM, Virdis P, Asara G, Frau M, Calvisi DF, Seddaiu MA, Pascale RM, Feo F. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF21 rat strain. Hepatology 2001;33:1110-7.
43. Teerguarden JG, Newton MA, Dragan YP, Pitot HC. Genome-wide loss of heterozygosity analysis of chemically induced rat hepatocellular carcinomas reveals elevated frequency of allelic imbalances on chromosomes 1, 6, 8, 11, 17, and 20. Mol Carcinog 2000;28:51-61.
44. Gariboldi M, Pascale RM, Manenti G. De Miglio MR, Calvisi D, Carru A, Dragani TA, Feo F. Analysis of loss of heterozygosity in neoplastic nodules induced by diethylnitrosamine in the resistant BFF1 rat strain. Carcinogenesis 1999;20:1363-8.
45. Marchio A, Medeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65.
46. Wong N, Lai P, Lee S-W, Fan S, Pang E, Liew C-T, Sheng Z, Lay J W-Y, Johnson PJ. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis. Relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999;154:37-43.
47. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Biomarkers Prev 1994;3:209-12.